Results 201 to 210 of about 1,496,674 (257)

Spatiotemporally Controlled Sequential Chemo‐Immunotherapy Activates Pyroptosis for Robust Anti‐Tumor Immunotherapy

Advanced Science, EarlyView.
A glutathione and ultrasound dual‐responsive cerasome achieves sequential co‐delivery of gemcitabine and BMS1166 in tumors. Chemotherapy priming followed by on‐demand PD‐L1 blockade synergistically amplifies anti‐tumor immunity, inhibiting primary tumor growth, distant metastasis and inducing durable immune memory.
Suhui Sun, Ruiqi Wu, Qingshuang Tang, Yunli Xu, Wanrui Shi, Mengxin Wang, Haonan Wang, Yan Luo, Cheng Ma, Xiaolong Liang   +9 more
wiley   +1 more source

Analysis of tumor-infiltrating lymphocytes as prognostic factor in triple-negative breast cancer: A protocol of systematic review and meta-analysis. [PDF]

PLoS One
Aquino LCM, Andrade EIS, Nunes LMF, Santos EM, Sarmento ACA, Medeiros KS, Gonçalves AK.   +6 more
europepmc   +1 more source

An orthotopic organoid-based model to study early CD8⁺ T cell dysfunction and immunotherapy response in colorectal cancer. [PDF]

Oncoimmunology
Lucantonio L, Schiano L, Sozio F, Kosta A, Peruzzi G, Molfetta R, Pietropaolo G, Laffranchi M, Campese AF, Bernardini G, Sozzani S, Gismondi A, Santoni A, Sciumè G, Helena S, Fionda C.   +15 more
europepmc   +1 more source

High TROP-2 expression as a predictor of poor neoadjuvant chemotherapy response in luminal B breast cancer: a retrospective clinicopathological study. [PDF]

BMC Cancer
Öztürk Ç, Çubukçu SS, Şen B, Öztürk AE, Okcu O.   +4 more
europepmc   +1 more source

ACBP/DBI Neutralization Stimulates Anticancer Immune Responses by Upregulating Lamin A in T Cells. [PDF]

Immunotargets Ther
Li S, López-Otín C, Maiuri MC, Martins I, Kroemer G.   +4 more
europepmc   +1 more source

AI-Based Analysis of Tumor-Infiltrating Lymphocytes and Homologous Recombination in Ovarian Cancer: JGOG3025-A1 Study. [PDF]

Cancer Sci
Hamada K, Hamanishi J, Matsumura N, Ueda A, Takamatsu S, Yoshihara K, Nagasawa T, Seki T, Kikuchi A, Fujimoto E, Taki M, Yamanoi K, Murakami R, Kudo H, Oda K, Shimada M, Okamoto A, Mandai M.   +17 more
europepmc   +1 more source

The PVR-TIGIT/CD96/CD226 axis: a novel immune checkpoint target in ovarian cancer. [PDF]

Front Immunol
Huang M, Zhang J, Huang H, Liu L, Zou Y.
europepmc   +1 more source